Skip to main content

PARP-Inhibitor Combination Treatments (Healthcare Education)

This RFP invites applications aimed at enhancing healthcare professional knowledge regarding PARP-inhibitor combination treatments in metastatic prostate cancer. The focus is on education around biomarker testing, safety, and efficacy, expected to significantly improve patient management and outcomes.

Overview

  • Funding for individual projects up to 350,000, within a total budget of 850,000.
  • Support for projects that increase knowledge on guideline adherence and best practices in clinical testing.
  • Encouragement of multi-supported educational programs.
  • Various approved formats for educational delivery, including webinars, live events, and multimedia resources.

Priority Areas

  • Testing Integration: Best practices for integrating biomarker testing into clinical practice, including ordering and interpreting results.
  • Efficacy and Safety Data: Understanding emerging data on PARP inhibitors' mechanisms, clinical safety, and treatment sequencing.
  • Community Care Best Practices: Guidelines for initiating appropriate care for mPC patients in community settings, including patient engagement in clinical trials.

Eligibility & Requirements

  • Applicant organizations must be located in the United States.
  • Eligible applicants include healthcare institutions, professional organizations, medical education companies, and academic institutions.
  • Grants are open only to organizations, not individuals or private practices.
  • Projects must be accredited if offering continuing education credits.
  • Applications will be assessed based on their relevance to education improvement in prostate cancer management, innovation, and expected impact on healthcare practices.

Timeline

  • Grant Application Due Date: August 21, 2025 (23:59 Eastern Time)
  • Anticipated Grant Award Notification: Week of September 15, 2025
  • Anticipated Project Duration: October 2025 - April 2027

How To Submit

  • Please go to www.cybergrants.com/pfizer/knowledge and sign in.
    • First-time users should click “Create your password”. [Note: there are individual portals for each grant application type. Please be sure to use the URL above.]
  • Click the “Start A New Knowledge Gap Application" button.
  • In the application:
    • For the question “What type of request are you submitting?” select Response to a Request for Proposal (RFP)
    • For the question “Are you replying to a Request for Proposal (RFP) as part of the Competitive Grant Program?” select Yes
    • Select the following Competitive Grant Program Name: 2025 ONC US PARPi mCRPC IME
    • Select the following Primary Area of Interest: Oncology – Genitourinary - KG

Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.